| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues: |
| Outside the United States | 212.5 | 177.9 | 83.2 | | | | | |
| United States | 588.8 | 524.9 | 415.7 | 302.1 | 174.2 | | | |
| International | | | | 60.2 | 9.7 | | | |
| Total revenues [+] | 801.2 | 702.8 | 498.8 | 362.3 | 183.9 | 107.6 | 84.2 | 72.9 |
| Products | 801.2 | 702.8 | 498.8 | 362.3 | 183.9 | | | |
| Revenue growth [+] | 14.0% | 40.9% | 37.7% | 97.0% | 70.9% | 27.7% | 15.6% | 46.5% |
| Outside the United States | 19.4% | 113.9% | | | | | | |
| United States | 12.2% | 26.3% | 37.6% | 73.4% | | | | |
| International | | | | 522.2% | | | | |
| Cost of goods sold | 388.2 | 326.6 | 238.3 | 168.1 | 94.0 | 63.5 | 60.7 | 46.3 |
| Gross profit | 413.0 | 376.2 | 260.5 | 194.2 | 89.8 | 44.1 | 23.6 | 26.6 |
| Gross margin | 51.5% | 53.5% | 52.2% | 53.6% | 48.9% | 41.0% | 28.0% | 36.5% |
| Selling, general and administrative | 335.7 | 261.5 | 204.9 | 165.7 | 105.2 | 86.4 | 82.8 | 78.6 |
| Research and development | 139.1 | 92.1 | 63.6 | 45.2 | 29.2 | 20.7 | 18.8 | 17.0 |
| Other operating expenses | -7.4 | -1.4 | -17.1 | | | | | |
| EBITDA [+] | -40.1 | 37.9 | 19.6 | -10.7 | -38.8 | -56.1 | -72.6 | -64.2 |
| EBITDA growth | -205.7% | 93.5% | -283.9% | -72.6% | -30.8% | -22.7% | 13.1% | -10.0% |
| EBITDA margin | -5.0% | 5.4% | 3.9% | -2.9% | -21.1% | -52.1% | -86.1% | -88.1% |
| Depreciation | 12.3 | 11.6 | 9.3 | 5.8 | 5.5 | 6.6 | 5.2 | 4.5 |
| EBITA | -52.4 | 26.2 | 10.3 | -16.4 | -44.3 | -62.6 | -77.8 | -68.7 |
| EBITA margin | -6.5% | 3.7% | 2.1% | -4.5% | -24.1% | -58.2% | -92.3% | -94.3% |
| Amortization of intangibles | 2.0 | 2.2 | 1.2 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 |
| EBIT [+] | -54.4 | 24.0 | 9.1 | -16.7 | -44.6 | -62.9 | -78.1 | -69.0 |
| EBIT growth | -326.3% | 163.3% | -154.6% | -62.5% | -29.1% | -19.4% | 13.1% | -8.8% |
| EBIT margin | -6.8% | 3.4% | 1.8% | -4.6% | -24.3% | -58.5% | -92.6% | -94.7% |
| Non-recurring items [+] | 38.5 | 1.4 | 17.1 | | | | | |
| Asset impairment | 7.6 | | | | | | | |
| In-process research & development | 31.0 | | | | | | | |
| Interest expense, net [+] | 6.2 | 6.0 | 12.8 | | 7.6 | 11.3 | 5.7 | 3.4 |
| Interest expense | 6.2 | 6.0 | 12.8 | | 7.6 | 11.3 | 5.7 | 3.7 |
| Interest income | | | | | | | | 0.3 |
| Other income (expense), net [+] | 6.2 | -0.7 | -15.5 | -7.9 | -70.4 | 1.3 | 0.3 | |
| Gain (loss) on debt retirement | | | | | -5.3 | | | |
| Change in fair value of warrants | 0.1 | -1.4 | -17.1 | -11.1 | -66.5 | 1.0 | | |
| Other | 0.0 | -6.8 | -28.3 | -7.9 | -77.9 | -10.1 | -5.4 | -3.4 |
| Pre-tax income | -92.9 | 15.9 | -36.3 | -24.6 | -122.6 | -73.0 | -83.5 | -72.4 |
| Income taxes | 1.7 | 0.3 | -1.9 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 |
| Tax rate | | 2.1% | 5.2% | | | | 0.0% | |
| Net income | -94.6 | 15.6 | -34.4 | -24.8 | -122.6 | -73.0 | -83.4 | -72.4 |
| Net margin | -11.8% | 2.2% | -6.9% | -6.8% | -66.7% | -67.9% | -99.0% | -99.4% |
| |
| Basic EPS [+] | ($1.47) | $0.25 | ($0.56) | ($0.42) | ($2.55) | ($12.86) | ($27.30) | ($25.04) |
| Growth | -696.8% | -143.8% | 33.2% | -83.4% | -80.2% | -52.9% | 9.0% | 632.8% |
| Diluted EPS [+] | ($1.47) | $0.24 | ($0.56) | ($0.42) | ($2.55) | ($12.86) | ($27.30) | ($25.04) |
| Growth | -709.6% | -142.9% | 33.2% | -83.4% | -80.2% | -52.9% | 9.0% | 632.8% |
| |
| Shares outstanding (basic) [+] | 64.1 | 63.0 | 61.0 | 58.5 | 48.1 | 5.7 | 3.1 | 2.9 |
| Growth | 1.8% | 3.3% | 4.2% | 21.6% | 747.8% | 85.7% | 5.7% | -87.6% |
| Shares outstanding (diluted) [+] | 64.1 | 64.3 | 61.0 | 58.5 | 48.1 | 5.7 | 3.1 | 2.9 |
| Growth | -0.3% | 5.5% | 4.2% | 21.6% | 747.8% | 85.7% | 5.7% | -87.6% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |